Illustration of Celastrol relieving inflammatory pain by modulating molecular pathways in the dorsal root ganglion.

Unlocking Natural Pain Relief: How Celastrol Can Soothe Inflammation

Beau Callahan in Health & Wellness December 2025 • 4 min read.

"Discover how Celastrol, a natural compound, can modulate HMGB1/NF-κB signaling pathways in the dorsal root ganglion to alleviate inflammatory pain."

Chronic inflammatory pain affects millions worldwide, significantly impacting quality of life. While conventional treatments offer relief, they often come with unwanted side effects, driving the search for alternative therapies.

Emerging research highlights the role of specific molecular pathways in the development and maintenance of chronic pain. One such pathway involves HMGB1 (high mobility group box 1) and NF-κB, both of which are crucial in the inflammatory response. When these pathways become overactive in the dorsal root ganglion (DRG) - a cluster of nerve cells in the spinal cord - it can lead to persistent pain.

Celastrol, a bioactive compound extracted from the Tripterygium wilfordii Hook plant, has garnered attention for its potent anti-inflammatory and antioxidant properties. Recent studies suggest that Celastrol may alleviate inflammatory pain by modulating the HMGB1/NF-κB signaling pathway, offering a novel approach to pain management.

How Celastrol Targets the HMGB1/NF-κB Pathway for Pain Relief?

Illustration of Celastrol relieving inflammatory pain by modulating molecular pathways in the dorsal root ganglion.

A recent study published in Neuroscience Letters investigated the effects of Celastrol on inflammatory pain in rats. The researchers aimed to determine if Celastrol could alleviate pain by modulating the HMGB1/NF-κB signaling pathway in the DRG. To induce inflammatory pain, the researchers used Complete Freund's Adjuvant (CFA), a common method for creating a chronic pain model in animals.

Here’s a breakdown of the study’s key methods:

Animal Model: Rats were injected with CFA to induce chronic inflammatory pain.
Treatment: Celastrol (1 mg/kg) was administered to the rats post-CFA injection.
Measurements: Paw withdrawal latency (PWL) was measured to assess pain sensitivity. Expression levels of HMGB1, NF-κB, GFAP, and CD11b in the DRG were determined using qRT-PCR and Western blot analysis.

The study's results indicated that Celastrol significantly reduced pain and inflammation in the rats. Specifically, Celastrol:

Suppressed HMGB1, NF-κB, and IL-1β mRNA and protein expression in the DRG.
Reduced COX-2 protein expression.
Down-regulated IL-6, IL-17, TNF-α, MCP-1, GFAP, and CD11b mRNA levels in the DRG.

The Future of Celastrol in Pain Management

These findings suggest that Celastrol may offer a promising therapeutic approach for managing inflammatory pain by targeting the HMGB1/NF-κB signaling pathway. While further research is needed to fully understand its mechanisms and potential applications in humans, Celastrol represents a significant step forward in the search for effective and natural pain relief solutions. More studies are required to determine optimal dosages, long-term effects, and potential interactions with other medications.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is Celastrol, and where does it come from?

Celastrol is a bioactive compound extracted from the Tripterygium wilfordii Hook plant. This natural extract is known for its potent anti-inflammatory and antioxidant properties, making it a subject of interest in the search for natural pain relief solutions. Recent studies suggest Celastrol can alleviate inflammatory pain by modulating the HMGB1/NF-κB signaling pathway.

How does Celastrol work to relieve inflammatory pain?

Celastrol alleviates inflammatory pain by modulating the HMGB1/NF-κB signaling pathway within the dorsal root ganglion (DRG). This pathway is crucial in the inflammatory response; when overactive, it leads to persistent pain. By targeting this pathway, Celastrol helps to suppress the expression of key inflammatory molecules, thus reducing pain and inflammation.

What role do HMGB1 and NF-κB play in chronic inflammatory pain?

HMGB1 (high mobility group box 1) and NF-κB are vital components of the inflammatory response. They are particularly significant in the context of chronic pain. When these pathways become overactive, especially in the dorsal root ganglion (DRG), they can lead to persistent pain. Celastrol's ability to modulate these pathways suggests it could be effective in treating chronic inflammatory pain by mitigating this overactivity.

What were the key findings of the study on Celastrol and inflammatory pain in rats?

The study revealed that Celastrol significantly reduced pain and inflammation in rats. Specifically, Celastrol suppressed the expression of HMGB1, NF-κB, and IL-1β in the DRG, reduced COX-2 protein expression, and down-regulated inflammatory markers such as IL-6, IL-17, TNF-α, and MCP-1. These results suggest that Celastrol targets multiple inflammatory pathways, leading to a reduction in pain sensitivity.

What are the next steps for Celastrol research in the context of pain management?

Further research is necessary to determine optimal dosages, long-term effects, and potential interactions with other medications. More studies are needed to fully understand the mechanisms of Celastrol and its potential applications in humans. These future studies will aim to validate Celastrol's effectiveness and safety, moving it closer to becoming a practical treatment for chronic inflammatory pain.